TrialPharmaceutical research2026

Population Pharmacokinetic/Pharmacodynamic Modeling of Volagidemab, a Glucagon Receptor Antagonist, in Healthy Chinese and US Subjects Following Single Subcutaneous Administration.

Zihan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.